Ronald Hoffman

Academic / Other · 6 registered clinical trials.

Status	Trial	Phase	Started
Completed	Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Th High Risk Polycythemia Vera, High Risk Essential Thrombocythemia	Phase 3	2011-09-01
Completed	Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia High Risk Polycythemia Vera, High Risk Essential Thrombocythemia	Phase 2	2011-09-01
Unknown	LBH589 (Panobinostat) for the Treatment of Myelofibrosis Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Post-Essential Thrombocythemia Related Myelofibrosis	Phase 1 / Phase 2	2009-09-01
Withdrawn	Clopidogrel and Aspirin for the Treatment of Polycythemia Vera Polycythemia Vera	Phase 2	2009-06-01
Unknown	CEP-701 (Lestaurtinib) in Myelofibrosis Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera	Phase 1 / Phase 2	2008-04-01
Terminated	Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis Myelofibrosis	Phase 2	2008-03-01